RT-149
|
Acquired QT syndrome. The mechanistic background
|
|
|
Wilhelm Haverkamp, Paulus Kirchhof, Lars Eckardt, Gerold Mönnig, Martin Borggrefe, Günter Breithardt.
Hospitalof the Westfälische Wilhelms-University, Department of Cardiology and Angiology and Institute for Arteriosclerosis Research, Münster, Germany
|
|
Mechanisms of torsade de pointes in acquired abnormal QT prolongation
|
|
Recently, in-vitro and in-vivo experimental studies have suggested that
early afterdepolarizations (EADs) and triggered activity may play an important role in the genesis of ventricular
tachyarrhythmias of the TDP-type. EADs are cellular depolarizations occurring either during phase 2 and 3 of the
transmembrane potential before repolarization is completed. These depolarizations may give rise to a premature
action potential or a train of action potentials when the threshold for activation is reached. The resulting
depolarization has been referred to as “triggered activity” since it is caused by a second nondriven upstroke
induced by an afterdepolarization. The induction of EADs in in-vitro preparations has been demonstrated for
almost all drugs known to cause abnormal QT-prolongation and TDP. Most of them exert their QT prolonging
effect which can be considered as a prerequisite for the development of EADs, by blocking the rapidly activating
component of the delayed rectifier potassium current IKr. Some investigators have suggested that TDP may be
initiated and also maintained by triggered activity simultaneously originating at several independent competing
foci. However, others have suggested that TDP may be initiated by triggered activity but maintained by a circus
movement reentry mechanism. El-Sherif and coworkers3 recently developed a canine in-vivo model of LQTS
using anthopleurin-A, an agent that prolongs action potential duration by slowing inactivation of the sodium
current. Using high-resolution tridimensional isochronal maps of activation and repolarization patterns, they
showed that the initial beat of all episodes of polymorphic ventricular tachycardia consistently arose as a
subendocardial focal activity whereas subsequent beats were due to successive reentrant excitation in the form
of rotating scrolls. Increased transmural electrical heterogeneity resulting from spatial differences in action
potential duration and morphology has been suggested as the substrate underlying reentrant activation.
TABLE I – Risk factors for drug-induced torsade de pointes
Prolonged baseline QT
|
Abnormally prolonged QT interval and QT during drug
|
T wave lability
|
T wave morphology changes during drug
|
Recent cardioversion from atrial fibrillation
|
Hypokalemia, hypomagnesemia
|
Diuretic use
|
Bradycardia
|
High drug doses or concentrations
|
Use of drugs interfering with the metabolism of drugs known to
cause torsade de pointes (e.g. inhibitors of cytochrome P450 enzymes like erythromycin,
ketoconazole, and grapefruit juice)
|
Rapid intravenous infusion
|
Female gender
|
Cardiac hypertrophy
|
Altered nutritional states (anorexia nervosa, diets, starvation)
|
Cerebrovascular diseases (e.g. intracranial hemorrhage)
|
|
|
|